McCue P A, Thomas R S, Schroeder D, Gubler M L, Sherman M I
Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322.
Cancer Res. 1988 Jul 1;48(13):3772-9.
We have examined the effects of dietary retinoids upon the growth and differentiation of seven embryonal carcinoma lines in mice. The control diet contained 4000 IU/mg retinyl palmitate; the other diets contained 2 x 10(5) IU/mg retinyl palmitate, 50 mg/kg all-trans-retinoic acid (RA), 100 mg/kg RA, and no retinoid. The RA-containing diets had little influence on tumor latency or incidence but did suppress growth of many of the tumors. Decreased tumor mass was, in most but not all instances, accompanied by an increased proportion of differentiated cells. Increased differentiation was most commonly quantitative rather than qualitative; i.e., there was a larger proportion of the same types of differentiated cells seen in tumors from the control diet group rather than an increase in the spectrum of cell types observed. Notably, tumors from two differentiation-defective embryonal carcinoma lines were refractory to both the differentiation-inducing and growth-suppressing properties of dietary RA. Taken together, our results suggest that dietary RA can reduce teratocarcinoma growth in part by promoting differentiation but that other mechanisms are likely to be involved. The therapeutic benefits that we observed with dietary RA were compromised by adverse effects, including failure of the mice to gain weight as effectively as those on the control diet. The effects of elevated levels of retinyl palmitate, or its omission from the diet, were much less striking than that of RA. Both modifications tended to decrease tumor latency but had little effect, if any, upon ultimate tumor mass. Elimination of retinoid from the diet failed to significantly reduce degree of differentiation in tumors which normally differentiate extensively in animals on retinoid-containing diets. Excess retinyl palmitate led to a marginal increase in differentiation in F9 tumors and a statistically significant increase in differentiation in OC15-S1 tumors. Tumors from other embryonal carcinoma lines did not contain elevated levels of differentiated cells. The interpretation of these results is complicated by our observations that although our dietary alteration in levels of palmitate were dramatic, they resulted in much more modest differences in circulating retinoid levels when compared with mice on the control diet.
我们研究了膳食类视黄醇对小鼠七种胚胎癌细胞系生长和分化的影响。对照饮食含有4000国际单位/毫克的棕榈酸视黄酯;其他饮食分别含有2×10⁵国际单位/毫克的棕榈酸视黄酯、50毫克/千克的全反式维甲酸(RA)、100毫克/千克的RA,以及不含类视黄醇。含RA的饮食对肿瘤潜伏期或发病率影响不大,但确实抑制了许多肿瘤的生长。在大多数但并非所有情况下,肿瘤质量的降低伴随着分化细胞比例的增加。分化增加最常见的是数量上的而非质量上的;也就是说,与对照饮食组肿瘤中观察到的相同类型分化细胞的比例更大,而不是观察到的细胞类型谱增加。值得注意的是,来自两个分化缺陷胚胎癌细胞系的肿瘤对膳食RA的诱导分化和抑制生长特性均无反应。综合来看,我们的结果表明,膳食RA可以部分通过促进分化来减少畸胎癌生长,但可能还涉及其他机制。我们观察到的膳食RA的治疗益处受到了不良反应的影响,包括小鼠体重增加不如对照饮食组有效。棕榈酸视黄酯水平升高或从饮食中去除其影响远不如RA显著。这两种改变都倾向于缩短肿瘤潜伏期,但对最终肿瘤质量影响甚微(如果有影响的话)。从饮食中去除类视黄醇并不能显著降低通常在含类视黄醇饮食的动物中广泛分化的肿瘤的分化程度。过量的棕榈酸视黄酯导致F9肿瘤分化略有增加,OC15 - S1肿瘤分化有统计学意义的增加。来自其他胚胎癌细胞系的肿瘤未含有升高水平的分化细胞。这些结果的解读因我们的观察而变得复杂,即尽管我们对棕榈酸水平的膳食改变很大,但与对照饮食的小鼠相比,它们导致的循环类视黄醇水平差异要小得多。